{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:44:49Z","timestamp":1781138689808,"version":"3.54.1"},"reference-count":31,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Unitaid","award":["2017-20-IMPAACT4TB"],"award-info":[{"award-number":["2017-20-IMPAACT4TB"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>While highly effective for reducing the risk of tuberculosis (TB) disease, TB preventive treatment (TPT) is underused among people living with HIV (PWH). We evaluated the effectiveness of a behavioural economics-based choice architecture approach to increase facility-level TPT prescribing to PWH in Malawi, Mozambique and Zimbabwe.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a cluster-randomised trial within the IMPAACT4TB 3HP rollout, in which 57 healthcare facilities were randomly assigned 1:1 to choice architecture (intervention) or standard TPT prescribing (control). The aim was to link TPT to antiretroviral therapy (ART) prescribing and to make TPT prescribing the default. The intervention was supported by clinician training and a default prescribing module built into the point-of-care HIV electronic medical record in Malawi and stickers placed in clients\u2019 clinical stationery in Mozambique and Zimbabwe. Data were collected in aggregate, and the primary outcome was the facility-level percentage of clients initiating ART who initiated TPT. The CAT study was registered with clinicaltrials.gov where it is listed as completed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Implementation occurred from October 2021 to September 2022 in Mozambique (20 facilities), April 2021 to March 2022 in Malawi (19 facilities) and June 2021 to May 2022 in Zimbabwe (18 facilities), for a total of 29 control arm and 28 choice architecture intervention arm facilities, respectively. Comparing control to intervention facilities, mean TPT prescribing to clients initiating ART was 70.9% vs 86.9% in Mozambique (difference: \u221216.0%; 95% CI: \u221238.3%, 6.3%; p=0.15), 56.5% vs 55.5% in Malawi (difference: 1.0%; 95%\u2009CI: \u221214.0%, 16.9%; p=0.89) and 56.2% vs 55.9% in Zimbabwe (difference: 0.2%; 95%\u2009CI: \u221225.2%, 25.8%; p=0.98).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The choice architecture intervention did not overcome barriers to TPT prescribing. While the intervention may have led to an improvement in TPT prescribing in Mozambique, no differences were observed in the other countries. Further innovation is needed to ensure that all clients initiating ART are either prescribed TPT or started on anti-TB treatment, as appropriate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04466293\">NCT04466293<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016921","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T20:55:15Z","timestamp":1748120115000},"page":"e016921","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04466293","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-4258","authenticated-orcid":false,"given":"Kate","family":"Shearer","sequence":"first","affiliation":[{"name":"Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-7487","authenticated-orcid":false,"given":"Bareng A S","family":"Nonyane","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Mulder","sequence":"additional","affiliation":[{"name":"TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, Den Haag, The Netherlands"},{"name":"Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Kaonga","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Nyirenda","sequence":"additional","affiliation":[{"name":"Department of HIV and AIDS, Government of Malawi Ministry of Health, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuzani","family":"Mbendera","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Elimination Program, Government of Malawi Ministry of Health, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Sambani","sequence":"additional","affiliation":[{"name":"Public Health Institute of Malawi, Government of Malawi Ministry of Health, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Valverde","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Aurum, Maputo, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savaiva","family":"Manguambe","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Aurum, Maputo, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Chiau","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Aurum, Maputo, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kawaza","sequence":"additional","affiliation":[{"name":"Clinton Health Access Initiative, Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Jokwiro","sequence":"additional","affiliation":[{"name":"Clinton Health Access Initiative, Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani","family":"Dube","sequence":"additional","affiliation":[{"name":"Clinton Health Access Initiative, Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsitsi","family":"Apollo","sequence":"additional","affiliation":[{"name":"Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Weiser","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Parktown, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Chihota","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Parktown, South Africa"},{"name":"School of Public Health, University of the Witwatersrand Johannesburg, Johannesburg, South Africa"},{"name":"Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J","family":"Churchyard","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Parktown, South Africa"},{"name":"School of Public Health, University of the Witwatersrand Johannesburg, Johannesburg, South Africa"},{"name":"Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Golub","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2025072914144361000_10.5.e016921.1","unstructured":"World Health Organization . Global tuberculosis report 2024. 2024. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240101531 [Accessed 20 Dec 2024]."},{"key":"2025072914144361000_10.5.e016921.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142290","article-title":"Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"10","author":"Ayele","year":"2015","journal-title":"PLoS ONE"},{"key":"2025072914144361000_10.5.e016921.3","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2352-3018(20)30299-X","article-title":"Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data","volume":"8","author":"Ross","year":"2021","journal-title":"Lancet HIV"},{"key":"2025072914144361000_10.5.e016921.4","unstructured":"World Health Organization Global Tuberculosis Programme and UNAIDS . Policy statement on preventive therapy against tuberculosis in people living with HIV: report of a meeting held in Geneva 18-20 February 1998. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/64509 [Accessed 30 May 2023]."},{"key":"2025072914144361000_10.5.e016921.5","unstructured":"World Health Organization . WHO operational handbook on tuberculosis. Module 1: prevention - tuberculosis preventive treatment. 2020. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240002906 [Accessed 11 Jul 2024]."},{"key":"2025072914144361000_10.5.e016921.6","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001098"},{"key":"2025072914144361000_10.5.e016921.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005136"},{"key":"2025072914144361000_10.5.e016921.8","unstructured":"United Nations . Political declaration of the high-level meeting of the United Nations general assembly on the fight against tuberculosis. 2018. Available: https:\/\/www.who.int\/publications\/m\/item\/political-declaration-of-the-un-general-assembly-high-level-meeting-on-the-fight-against-tuberculosis [Accessed 11 Jul 2024]."},{"key":"2025072914144361000_10.5.e016921.9","unstructured":"World Health Organization . Global tuberculosis report 2023. 2023. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240083851 [Accessed 11 Jul 2024]."},{"key":"2025072914144361000_10.5.e016921.10","unstructured":"World Health Organization . The End TB strategy. 2015. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2015.19 [Accessed 11 Jul 2024]."},{"key":"2025072914144361000_10.5.e016921.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212035","article-title":"Health system barriers to implementation of TB preventive strategies in South African primary care facilities","volume":"14","author":"Van Ginderdeuren","year":"2019","journal-title":"PLoS One"},{"key":"2025072914144361000_10.5.e016921.12","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0378"},{"key":"2025072914144361000_10.5.e016921.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-7652-x","article-title":"Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons","volume":"19","author":"Kagujje","year":"2019","journal-title":"BMC Public Health"},{"key":"2025072914144361000_10.5.e016921.14","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20010621","article-title":"Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts","volume":"20","author":"Assefa","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025072914144361000_10.5.e016921.15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5588\/ijtld.20.0956","article-title":"Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis","volume":"25","author":"Kalema","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025072914144361000_10.5.e016921.16","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1016\/S2352-3018(22)00166-7","article-title":"A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial","volume":"9","author":"Kakande","year":"2022","journal-title":"Lancet HIV"},{"key":"2025072914144361000_10.5.e016921.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70187-7"},{"key":"2025072914144361000_10.5.e016921.18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5588\/pha.17.0011","article-title":"Increasing isoniazid preventive therapy uptake in an HIV program in rural Papua New Guinea","volume":"7","author":"Carmone","year":"2017","journal-title":"Public Health Action"},{"key":"2025072914144361000_10.5.e016921.19","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25803","article-title":"A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary healthcare clinics in South Africa","volume":"24","author":"Gengiah","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"2025072914144361000_10.5.e016921.20","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0315"},{"key":"2025072914144361000_10.5.e016921.21","unstructured":"IMPAACT4TB. Available: https:\/\/impaact4tb.org [Accessed 09 Feb 2024]."},{"key":"2025072914144361000_10.5.e016921.22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2307\/j.ctv550cbm.31","volume-title":"The behavioral foundations of public policy","volume":"2013","author":"Thaler","year":"2013"},{"key":"2025072914144361000_10.5.e016921.23","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26074","article-title":"Strengthening HIV and HIV co-morbidity care in low-and middle-income countries: insights from behavioural economics to improve healthcare worker behaviour","volume":"26","author":"Mishra","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"2025072914144361000_10.5.e016921.24","doi-asserted-by":"publisher","DOI":"10.1191\/1740774504cn024oa"},{"key":"2025072914144361000_10.5.e016921.25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1536867X1801800204","article-title":"cvcrand and cptest: Commands for efficient design and analysis of cluster randomized trials using constrained randomization and permutation tests","volume":"18","author":"Gallis","year":"2018","journal-title":"Stata J"},{"key":"2025072914144361000_10.5.e016921.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11002-012-9186-1"},{"key":"2025072914144361000_10.5.e016921.27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5588\/pha.20.0020","article-title":"Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa","volume":"10","author":"Caturegli","year":"2020","journal-title":"Public Health Action"},{"key":"2025072914144361000_10.5.e016921.28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11904-022-00614-0","article-title":"HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis","volume":"19","author":"Soh","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025072914144361000_10.5.e016921.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.892"},{"key":"2025072914144361000_10.5.e016921.30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajem.2023.12.029","article-title":"Evaluation of an emergency department opt-out provider-driven HIV and syphilis screening and linkage-to-care program","volume":"77","author":"Scott","year":"2024","journal-title":"Am J Emerg Med"},{"key":"2025072914144361000_10.5.e016921.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10493-9","article-title":"Health care providers acceptance of default prescribing of TB preventive treatment for people living with HIV in Malawi: a qualitative study","volume":"24","author":"De Groot","year":"2024","journal-title":"BMC Health Serv Res"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:14:51Z","timestamp":1753823691000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjgh-2024-016921"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016921","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}